 | • レポートコード：MRC2Q12-17158 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、先天性心疾患オクルーダー装置の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に先天性心疾患オクルーダー装置のグローバル市場のxxx％を占める「ASDオクルーダー」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 先天性心疾患オクルーダー装置の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの先天性心疾患オクルーダー装置市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 先天性心疾患オクルーダー装置のグローバル主要プレイヤーには、Abbott、Boston Scientific、LifeTech、Lepu Medical、Occlutech、W. L. Gore & Associates、Starway、Coherex Medical、Cardia、MicroPortなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 先天性心疾患オクルーダー装置市場は、種類と用途によって区分されます。世界の先天性心疾患オクルーダー装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ASDオクルーダー、VSDオクルーダー、PDAオクルーダー 【用途別セグメント】 病院、診療所 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 先天性心疾患オクルーダー装置製品概要 - 種類別市場（ASDオクルーダー、VSDオクルーダー、PDAオクルーダー） - 用途別市場（病院、診療所） - 調査の目的 ・エグゼクティブサマリー - 世界の先天性心疾患オクルーダー装置販売量予測2017-2028 - 世界の先天性心疾患オクルーダー装置売上予測2017-2028 - 先天性心疾患オクルーダー装置の地域別販売量 - 先天性心疾患オクルーダー装置の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別先天性心疾患オクルーダー装置販売量 - 主要メーカー別先天性心疾患オクルーダー装置売上 - 主要メーカー別先天性心疾患オクルーダー装置価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ASDオクルーダー、VSDオクルーダー、PDAオクルーダー） - 先天性心疾患オクルーダー装置の種類別販売量 - 先天性心疾患オクルーダー装置の種類別売上 - 先天性心疾患オクルーダー装置の種類別価格 ・用途別市場規模（病院、診療所） - 先天性心疾患オクルーダー装置の用途別販売量 - 先天性心疾患オクルーダー装置の用途別売上 - 先天性心疾患オクルーダー装置の用途別価格 ・北米市場 - 北米の先天性心疾患オクルーダー装置市場規模（種類別、用途別） - 主要国別の先天性心疾患オクルーダー装置市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの先天性心疾患オクルーダー装置市場規模（種類別、用途別） - 主要国別の先天性心疾患オクルーダー装置市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の先天性心疾患オクルーダー装置市場規模（種類別、用途別） - 主要国別の先天性心疾患オクルーダー装置市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の先天性心疾患オクルーダー装置市場規模（種類別、用途別） - 主要国別の先天性心疾患オクルーダー装置市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの先天性心疾患オクルーダー装置市場規模（種類別、用途別） - 主要国別の先天性心疾患オクルーダー装置市場規模（トルコ、サウジアラビア） ・企業情報 Abbott、Boston Scientific、LifeTech、Lepu Medical、Occlutech、W. L. Gore & Associates、Starway、Coherex Medical、Cardia、MicroPort ・産業チェーン及び販売チャネル分析 - 先天性心疾患オクルーダー装置の産業チェーン分析 - 先天性心疾患オクルーダー装置の原材料 - 先天性心疾患オクルーダー装置の生産プロセス - 先天性心疾患オクルーダー装置の販売及びマーケティング - 先天性心疾患オクルーダー装置の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 先天性心疾患オクルーダー装置の産業動向 - 先天性心疾患オクルーダー装置のマーケットドライバー - 先天性心疾患オクルーダー装置の課題 - 先天性心疾患オクルーダー装置の阻害要因 ・主な調査結果 |
CHD occluders are medical devices intended for the closure of the remnant opening, or a defect, in the heart resulting from congenital abnormal development.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Congenital Heart Disease Occluder Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Congenital Heart Disease Occluder Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Congenital Heart Disease Occluder Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Congenital Heart Disease Occluder Device include Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates, Starway, Coherex Medical and Cardia, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Congenital Heart Disease Occluder Device manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Congenital Heart Disease Occluder Device market. Further, it explains the major drivers and regional dynamics of the global Congenital Heart Disease Occluder Device market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Congenital Heart Disease Occluder Device Segment by Type
ASD Occluder
VSD Occluder
PDA Occluder
Congenital Heart Disease Occluder Device Segment by Application
Hospitals
Clinics
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Congenital Heart Disease Occluder Device market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Congenital Heart Disease Occluder Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Congenital Heart Disease Occluder Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Congenital Heart Disease Occluder Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Congenital Heart Disease Occluder Device sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Congenital Heart Disease Occluder Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Congenital Heart Disease Occluder Device sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates, Starway, Coherex Medical and Cardia, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Congenital Heart Disease Occluder Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Congenital Heart Disease Occluder Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Congenital Heart Disease Occluder Device sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Congenital Heart Disease Occluder Device Product Introduction
1.2 Market by Type
1.2.1 Global Congenital Heart Disease Occluder Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 ASD Occluder
1.2.3 VSD Occluder
1.2.4 PDA Occluder
1.3 Market by Application
1.3.1 Global Congenital Heart Disease Occluder Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Congenital Heart Disease Occluder Device Sales Estimates and Forecasts 2017-2028
2.2 Global Congenital Heart Disease Occluder Device Revenue Estimates and Forecasts 2017-2028
2.3 Global Congenital Heart Disease Occluder Device Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Congenital Heart Disease Occluder Device Sales by Region
2.4.1 Global Congenital Heart Disease Occluder Device Sales by Region (2017-2022)
2.4.2 Global Sales Congenital Heart Disease Occluder Device by Region (2023-2028)
2.5 Global Congenital Heart Disease Occluder Device Revenue by Region
2.5.1 Global Congenital Heart Disease Occluder Device Revenue by Region (2017-2022)
2.5.2 Global Congenital Heart Disease Occluder Device Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Congenital Heart Disease Occluder Device Sales by Manufacturers
3.1.1 Global Top Congenital Heart Disease Occluder Device Manufacturers by Sales (2017-2022)
3.1.2 Global Congenital Heart Disease Occluder Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Congenital Heart Disease Occluder Device in 2021
3.2 Global Congenital Heart Disease Occluder Device Revenue by Manufacturers
3.2.1 Global Congenital Heart Disease Occluder Device Revenue by Manufacturers (2017-2022)
3.2.2 Global Congenital Heart Disease Occluder Device Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Congenital Heart Disease Occluder Device Revenue in 2021
3.3 Global Congenital Heart Disease Occluder Device Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Congenital Heart Disease Occluder Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Congenital Heart Disease Occluder Device Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Congenital Heart Disease Occluder Device Sales by Type
4.1.1 Global Congenital Heart Disease Occluder Device Historical Sales by Type (2017-2022)
4.1.2 Global Congenital Heart Disease Occluder Device Forecasted Sales by Type (2023-2028)
4.1.3 Global Congenital Heart Disease Occluder Device Sales Market Share by Type (2017-2028)
4.2 Global Congenital Heart Disease Occluder Device Revenue by Type
4.2.1 Global Congenital Heart Disease Occluder Device Historical Revenue by Type (2017-2022)
4.2.2 Global Congenital Heart Disease Occluder Device Forecasted Revenue by Type (2023-2028)
4.2.3 Global Congenital Heart Disease Occluder Device Revenue Market Share by Type (2017-2028)
4.3 Global Congenital Heart Disease Occluder Device Price by Type
4.3.1 Global Congenital Heart Disease Occluder Device Price by Type (2017-2022)
4.3.2 Global Congenital Heart Disease Occluder Device Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Congenital Heart Disease Occluder Device Sales by Application
5.1.1 Global Congenital Heart Disease Occluder Device Historical Sales by Application (2017-2022)
5.1.2 Global Congenital Heart Disease Occluder Device Forecasted Sales by Application (2023-2028)
5.1.3 Global Congenital Heart Disease Occluder Device Sales Market Share by Application (2017-2028)
5.2 Global Congenital Heart Disease Occluder Device Revenue by Application
5.2.1 Global Congenital Heart Disease Occluder Device Historical Revenue by Application (2017-2022)
5.2.2 Global Congenital Heart Disease Occluder Device Forecasted Revenue by Application (2023-2028)
5.2.3 Global Congenital Heart Disease Occluder Device Revenue Market Share by Application (2017-2028)
5.3 Global Congenital Heart Disease Occluder Device Price by Application
5.3.1 Global Congenital Heart Disease Occluder Device Price by Application (2017-2022)
5.3.2 Global Congenital Heart Disease Occluder Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America Congenital Heart Disease Occluder Device Market Size by Type
6.1.1 North America Congenital Heart Disease Occluder Device Sales by Type (2017-2028)
6.1.2 North America Congenital Heart Disease Occluder Device Revenue by Type (2017-2028)
6.2 North America Congenital Heart Disease Occluder Device Market Size by Application
6.2.1 North America Congenital Heart Disease Occluder Device Sales by Application (2017-2028)
6.2.2 North America Congenital Heart Disease Occluder Device Revenue by Application (2017-2028)
6.3 North America Congenital Heart Disease Occluder Device Market Size by Country
6.3.1 North America Congenital Heart Disease Occluder Device Sales by Country (2017-2028)
6.3.2 North America Congenital Heart Disease Occluder Device Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Congenital Heart Disease Occluder Device Market Size by Type
7.1.1 Europe Congenital Heart Disease Occluder Device Sales by Type (2017-2028)
7.1.2 Europe Congenital Heart Disease Occluder Device Revenue by Type (2017-2028)
7.2 Europe Congenital Heart Disease Occluder Device Market Size by Application
7.2.1 Europe Congenital Heart Disease Occluder Device Sales by Application (2017-2028)
7.2.2 Europe Congenital Heart Disease Occluder Device Revenue by Application (2017-2028)
7.3 Europe Congenital Heart Disease Occluder Device Market Size by Country
7.3.1 Europe Congenital Heart Disease Occluder Device Sales by Country (2017-2028)
7.3.2 Europe Congenital Heart Disease Occluder Device Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Congenital Heart Disease Occluder Device Market Size by Type
8.1.1 Asia Pacific Congenital Heart Disease Occluder Device Sales by Type (2017-2028)
8.1.2 Asia Pacific Congenital Heart Disease Occluder Device Revenue by Type (2017-2028)
8.2 Asia Pacific Congenital Heart Disease Occluder Device Market Size by Application
8.2.1 Asia Pacific Congenital Heart Disease Occluder Device Sales by Application (2017-2028)
8.2.2 Asia Pacific Congenital Heart Disease Occluder Device Revenue by Application (2017-2028)
8.3 Asia Pacific Congenital Heart Disease Occluder Device Market Size by Region
8.3.1 Asia Pacific Congenital Heart Disease Occluder Device Sales by Region (2017-2028)
8.3.2 Asia Pacific Congenital Heart Disease Occluder Device Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Congenital Heart Disease Occluder Device Market Size by Type
9.1.1 Latin America Congenital Heart Disease Occluder Device Sales by Type (2017-2028)
9.1.2 Latin America Congenital Heart Disease Occluder Device Revenue by Type (2017-2028)
9.2 Latin America Congenital Heart Disease Occluder Device Market Size by Application
9.2.1 Latin America Congenital Heart Disease Occluder Device Sales by Application (2017-2028)
9.2.2 Latin America Congenital Heart Disease Occluder Device Revenue by Application (2017-2028)
9.3 Latin America Congenital Heart Disease Occluder Device Market Size by Country
9.3.1 Latin America Congenital Heart Disease Occluder Device Sales by Country (2017-2028)
9.3.2 Latin America Congenital Heart Disease Occluder Device Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Congenital Heart Disease Occluder Device Market Size by Type
10.1.1 Middle East and Africa Congenital Heart Disease Occluder Device Sales by Type (2017-2028)
10.1.2 Middle East and Africa Congenital Heart Disease Occluder Device Revenue by Type (2017-2028)
10.2 Middle East and Africa Congenital Heart Disease Occluder Device Market Size by Application
10.2.1 Middle East and Africa Congenital Heart Disease Occluder Device Sales by Application (2017-2028)
10.2.2 Middle East and Africa Congenital Heart Disease Occluder Device Revenue by Application (2017-2028)
10.3 Middle East and Africa Congenital Heart Disease Occluder Device Market Size by Country
10.3.1 Middle East and Africa Congenital Heart Disease Occluder Device Sales by Country (2017-2028)
10.3.2 Middle East and Africa Congenital Heart Disease Occluder Device Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Overview
11.1.3 Abbott Congenital Heart Disease Occluder Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Corporation Information
11.2.2 Boston Scientific Overview
11.2.3 Boston Scientific Congenital Heart Disease Occluder Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Boston Scientific Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boston Scientific Recent Developments
11.3 LifeTech
11.3.1 LifeTech Corporation Information
11.3.2 LifeTech Overview
11.3.3 LifeTech Congenital Heart Disease Occluder Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 LifeTech Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 LifeTech Recent Developments
11.4 Lepu Medical
11.4.1 Lepu Medical Corporation Information
11.4.2 Lepu Medical Overview
11.4.3 Lepu Medical Congenital Heart Disease Occluder Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Lepu Medical Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lepu Medical Recent Developments
11.5 Occlutech
11.5.1 Occlutech Corporation Information
11.5.2 Occlutech Overview
11.5.3 Occlutech Congenital Heart Disease Occluder Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Occlutech Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Occlutech Recent Developments
11.6 W. L. Gore & Associates
11.6.1 W. L. Gore & Associates Corporation Information
11.6.2 W. L. Gore & Associates Overview
11.6.3 W. L. Gore & Associates Congenital Heart Disease Occluder Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 W. L. Gore & Associates Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 W. L. Gore & Associates Recent Developments
11.7 Starway
11.7.1 Starway Corporation Information
11.7.2 Starway Overview
11.7.3 Starway Congenital Heart Disease Occluder Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Starway Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Starway Recent Developments
11.8 Coherex Medical
11.8.1 Coherex Medical Corporation Information
11.8.2 Coherex Medical Overview
11.8.3 Coherex Medical Congenital Heart Disease Occluder Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Coherex Medical Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Coherex Medical Recent Developments
11.9 Cardia
11.9.1 Cardia Corporation Information
11.9.2 Cardia Overview
11.9.3 Cardia Congenital Heart Disease Occluder Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Cardia Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cardia Recent Developments
11.10 MicroPort
11.10.1 MicroPort Corporation Information
11.10.2 MicroPort Overview
11.10.3 MicroPort Congenital Heart Disease Occluder Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 MicroPort Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 MicroPort Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Congenital Heart Disease Occluder Device Industry Chain Analysis
12.2 Congenital Heart Disease Occluder Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Congenital Heart Disease Occluder Device Production Mode & Process
12.4 Congenital Heart Disease Occluder Device Sales and Marketing
12.4.1 Congenital Heart Disease Occluder Device Sales Channels
12.4.2 Congenital Heart Disease Occluder Device Distributors
12.5 Congenital Heart Disease Occluder Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Congenital Heart Disease Occluder Device Industry Trends
13.2 Congenital Heart Disease Occluder Device Market Drivers
13.3 Congenital Heart Disease Occluder Device Market Challenges
13.4 Congenital Heart Disease Occluder Device Market Restraints
14 Key Findings in The Global Congenital Heart Disease Occluder Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Congenital Heart Disease Occluder Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of ASD Occluder
Table 3. Major Manufacturers of VSD Occluder
Table 4. Major Manufacturers of PDA Occluder
Table 5. Global Congenital Heart Disease Occluder Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Congenital Heart Disease Occluder Device Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Congenital Heart Disease Occluder Device Sales by Region (2017-2022) & (Units)
Table 8. Global Congenital Heart Disease Occluder Device Sales Market Share by Region (2017-2022)
Table 9. Global Congenital Heart Disease Occluder Device Sales by Region (2023-2028) & (Units)
Table 10. Global Congenital Heart Disease Occluder Device Sales Market Share by Region (2023-2028)
Table 11. Global Congenital Heart Disease Occluder Device Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Congenital Heart Disease Occluder Device Revenue Market Share by Region (2017-2022)
Table 13. Global Congenital Heart Disease Occluder Device Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Congenital Heart Disease Occluder Device Revenue Market Share by Region (2023-2028)
Table 15. Global Congenital Heart Disease Occluder Device Sales by Manufacturers (2017-2022) & (Units)
Table 16. Global Congenital Heart Disease Occluder Device Sales Share by Manufacturers (2017-2022)
Table 17. Global Congenital Heart Disease Occluder Device Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Congenital Heart Disease Occluder Device Revenue Share by Manufacturers (2017-2022)
Table 19. Congenital Heart Disease Occluder Device Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Congenital Heart Disease Occluder Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Congenital Heart Disease Occluder Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congenital Heart Disease Occluder Device as of 2021)
Table 22. Congenital Heart Disease Occluder Device Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Congenital Heart Disease Occluder Device Product Offered
Table 24. Date of Manufacturers Enter into Congenital Heart Disease Occluder Device Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Congenital Heart Disease Occluder Device Sales by Type (2017-2022) & (Units)
Table 27. Global Congenital Heart Disease Occluder Device Sales by Type (2023-2028) & (Units)
Table 28. Global Congenital Heart Disease Occluder Device Sales Share by Type (2017-2022)
Table 29. Global Congenital Heart Disease Occluder Device Sales Share by Type (2023-2028)
Table 30. Global Congenital Heart Disease Occluder Device Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Congenital Heart Disease Occluder Device Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Congenital Heart Disease Occluder Device Revenue Share by Type (2017-2022)
Table 33. Global Congenital Heart Disease Occluder Device Revenue Share by Type (2023-2028)
Table 34. Congenital Heart Disease Occluder Device Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Congenital Heart Disease Occluder Device Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Congenital Heart Disease Occluder Device Sales by Application (2017-2022) & (Units)
Table 37. Global Congenital Heart Disease Occluder Device Sales by Application (2023-2028) & (Units)
Table 38. Global Congenital Heart Disease Occluder Device Sales Share by Application (2017-2022)
Table 39. Global Congenital Heart Disease Occluder Device Sales Share by Application (2023-2028)
Table 40. Global Congenital Heart Disease Occluder Device Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Congenital Heart Disease Occluder Device Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Congenital Heart Disease Occluder Device Revenue Share by Application (2017-2022)
Table 43. Global Congenital Heart Disease Occluder Device Revenue Share by Application (2023-2028)
Table 44. Congenital Heart Disease Occluder Device Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Congenital Heart Disease Occluder Device Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Congenital Heart Disease Occluder Device Sales by Type (2017-2022) & (Units)
Table 47. North America Congenital Heart Disease Occluder Device Sales by Type (2023-2028) & (Units)
Table 48. North America Congenital Heart Disease Occluder Device Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Congenital Heart Disease Occluder Device Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Congenital Heart Disease Occluder Device Sales by Application (2017-2022) & (Units)
Table 51. North America Congenital Heart Disease Occluder Device Sales by Application (2023-2028) & (Units)
Table 52. North America Congenital Heart Disease Occluder Device Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Congenital Heart Disease Occluder Device Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Congenital Heart Disease Occluder Device Sales by Country (2017-2022) & (Units)
Table 55. North America Congenital Heart Disease Occluder Device Sales by Country (2023-2028) & (Units)
Table 56. North America Congenital Heart Disease Occluder Device Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Congenital Heart Disease Occluder Device Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Congenital Heart Disease Occluder Device Sales by Type (2017-2022) & (Units)
Table 59. Europe Congenital Heart Disease Occluder Device Sales by Type (2023-2028) & (Units)
Table 60. Europe Congenital Heart Disease Occluder Device Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Congenital Heart Disease Occluder Device Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Congenital Heart Disease Occluder Device Sales by Application (2017-2022) & (Units)
Table 63. Europe Congenital Heart Disease Occluder Device Sales by Application (2023-2028) & (Units)
Table 64. Europe Congenital Heart Disease Occluder Device Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Congenital Heart Disease Occluder Device Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Congenital Heart Disease Occluder Device Sales by Country (2017-2022) & (Units)
Table 67. Europe Congenital Heart Disease Occluder Device Sales by Country (2023-2028) & (Units)
Table 68. Europe Congenital Heart Disease Occluder Device Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Congenital Heart Disease Occluder Device Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Congenital Heart Disease Occluder Device Sales by Type (2017-2022) & (Units)
Table 71. Asia Pacific Congenital Heart Disease Occluder Device Sales by Type (2023-2028) & (Units)
Table 72. Asia Pacific Congenital Heart Disease Occluder Device Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Congenital Heart Disease Occluder Device Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Congenital Heart Disease Occluder Device Sales by Application (2017-2022) & (Units)
Table 75. Asia Pacific Congenital Heart Disease Occluder Device Sales by Application (2023-2028) & (Units)
Table 76. Asia Pacific Congenital Heart Disease Occluder Device Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Congenital Heart Disease Occluder Device Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Congenital Heart Disease Occluder Device Sales by Region (2017-2022) & (Units)
Table 79. Asia Pacific Congenital Heart Disease Occluder Device Sales by Region (2023-2028) & (Units)
Table 80. Asia Pacific Congenital Heart Disease Occluder Device Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Congenital Heart Disease Occluder Device Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Congenital Heart Disease Occluder Device Sales by Type (2017-2022) & (Units)
Table 83. Latin America Congenital Heart Disease Occluder Device Sales by Type (2023-2028) & (Units)
Table 84. Latin America Congenital Heart Disease Occluder Device Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Congenital Heart Disease Occluder Device Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Congenital Heart Disease Occluder Device Sales by Application (2017-2022) & (Units)
Table 87. Latin America Congenital Heart Disease Occluder Device Sales by Application (2023-2028) & (Units)
Table 88. Latin America Congenital Heart Disease Occluder Device Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Congenital Heart Disease Occluder Device Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Congenital Heart Disease Occluder Device Sales by Country (2017-2022) & (Units)
Table 91. Latin America Congenital Heart Disease Occluder Device Sales by Country (2023-2028) & (Units)
Table 92. Latin America Congenital Heart Disease Occluder Device Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Congenital Heart Disease Occluder Device Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Congenital Heart Disease Occluder Device Sales by Type (2017-2022) & (Units)
Table 95. Middle East and Africa Congenital Heart Disease Occluder Device Sales by Type (2023-2028) & (Units)
Table 96. Middle East and Africa Congenital Heart Disease Occluder Device Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Congenital Heart Disease Occluder Device Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Congenital Heart Disease Occluder Device Sales by Application (2017-2022) & (Units)
Table 99. Middle East and Africa Congenital Heart Disease Occluder Device Sales by Application (2023-2028) & (Units)
Table 100. Middle East and Africa Congenital Heart Disease Occluder Device Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Congenital Heart Disease Occluder Device Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Congenital Heart Disease Occluder Device Sales by Country (2017-2022) & (Units)
Table 103. Middle East and Africa Congenital Heart Disease Occluder Device Sales by Country (2023-2028) & (Units)
Table 104. Middle East and Africa Congenital Heart Disease Occluder Device Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Congenital Heart Disease Occluder Device Revenue by Country (2023-2028) & (US$ Million)
Table 106. Abbott Corporation Information
Table 107. Abbott Description and Major Businesses
Table 108. Abbott Congenital Heart Disease Occluder Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Abbott Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Abbott Recent Developments
Table 111. Boston Scientific Corporation Information
Table 112. Boston Scientific Description and Major Businesses
Table 113. Boston Scientific Congenital Heart Disease Occluder Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Boston Scientific Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Boston Scientific Recent Developments
Table 116. LifeTech Corporation Information
Table 117. LifeTech Description and Major Businesses
Table 118. LifeTech Congenital Heart Disease Occluder Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. LifeTech Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. LifeTech Recent Developments
Table 121. Lepu Medical Corporation Information
Table 122. Lepu Medical Description and Major Businesses
Table 123. Lepu Medical Congenital Heart Disease Occluder Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Lepu Medical Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Lepu Medical Recent Developments
Table 126. Occlutech Corporation Information
Table 127. Occlutech Description and Major Businesses
Table 128. Occlutech Congenital Heart Disease Occluder Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Occlutech Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Occlutech Recent Developments
Table 131. W. L. Gore & Associates Corporation Information
Table 132. W. L. Gore & Associates Description and Major Businesses
Table 133. W. L. Gore & Associates Congenital Heart Disease Occluder Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. W. L. Gore & Associates Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. W. L. Gore & Associates Recent Developments
Table 136. Starway Corporation Information
Table 137. Starway Description and Major Businesses
Table 138. Starway Congenital Heart Disease Occluder Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Starway Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Starway Recent Developments
Table 141. Coherex Medical Corporation Information
Table 142. Coherex Medical Description and Major Businesses
Table 143. Coherex Medical Congenital Heart Disease Occluder Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Coherex Medical Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Coherex Medical Recent Developments
Table 146. Cardia Corporation Information
Table 147. Cardia Description and Major Businesses
Table 148. Cardia Congenital Heart Disease Occluder Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Cardia Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Cardia Recent Developments
Table 151. MicroPort Corporation Information
Table 152. MicroPort Description and Major Businesses
Table 153. MicroPort Congenital Heart Disease Occluder Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. MicroPort Congenital Heart Disease Occluder Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. MicroPort Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Congenital Heart Disease Occluder Device Distributors List
Table 159. Congenital Heart Disease Occluder Device Customers List
Table 160. Congenital Heart Disease Occluder Device Market Trends
Table 161. Congenital Heart Disease Occluder Device Market Drivers
Table 162. Congenital Heart Disease Occluder Device Market Challenges
Table 163. Congenital Heart Disease Occluder Device Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Congenital Heart Disease Occluder Device Product Picture
Figure 2. Global Congenital Heart Disease Occluder Device Market Share by Type in 2021 & 2028
Figure 3. ASD Occluder Product Picture
Figure 4. VSD Occluder Product Picture
Figure 5. PDA Occluder Product Picture
Figure 6. Global Congenital Heart Disease Occluder Device Market Share by Application in 2021 & 2028
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Congenital Heart Disease Occluder Device Report Years Considered
Figure 10. Global Congenital Heart Disease Occluder Device Sales 2017-2028 (Units)
Figure 11. Global Congenital Heart Disease Occluder Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Congenital Heart Disease Occluder Device Revenue 2017-2028 (US$ Million)
Figure 13. Global Congenital Heart Disease Occluder Device Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Congenital Heart Disease Occluder Device Sales Market Share by Region (2017-2022)
Figure 15. Global Congenital Heart Disease Occluder Device Sales Market Share by Region (2023-2028)
Figure 16. North America Congenital Heart Disease Occluder Device Sales YoY (2017-2028) & (Units)
Figure 17. North America Congenital Heart Disease Occluder Device Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Congenital Heart Disease Occluder Device Sales YoY (2017-2028) & (Units)
Figure 19. Europe Congenital Heart Disease Occluder Device Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Congenital Heart Disease Occluder Device Sales YoY (2017-2028) & (Units)
Figure 21. Asia-Pacific Congenital Heart Disease Occluder Device Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Congenital Heart Disease Occluder Device Sales YoY (2017-2028) & (Units)
Figure 23. Latin America Congenital Heart Disease Occluder Device Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Congenital Heart Disease Occluder Device Sales YoY (2017-2028) & (Units)
Figure 25. Middle East & Africa Congenital Heart Disease Occluder Device Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Congenital Heart Disease Occluder Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Congenital Heart Disease Occluder Device in the World: Market Share by Congenital Heart Disease Occluder Device Revenue in 2021
Figure 28. Global Congenital Heart Disease Occluder Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Congenital Heart Disease Occluder Device Sales Market Share by Type (2017-2028)
Figure 30. Global Congenital Heart Disease Occluder Device Revenue Market Share by Type (2017-2028)
Figure 31. Global Congenital Heart Disease Occluder Device Sales Market Share by Application (2017-2028)
Figure 32. Global Congenital Heart Disease Occluder Device Revenue Market Share by Application (2017-2028)
Figure 33. North America Congenital Heart Disease Occluder Device Sales Market Share by Type (2017-2028)
Figure 34. North America Congenital Heart Disease Occluder Device Revenue Market Share by Type (2017-2028)
Figure 35. North America Congenital Heart Disease Occluder Device Sales Market Share by Application (2017-2028)
Figure 36. North America Congenital Heart Disease Occluder Device Revenue Market Share by Application (2017-2028)
Figure 37. North America Congenital Heart Disease Occluder Device Sales Share by Country (2017-2028)
Figure 38. North America Congenital Heart Disease Occluder Device Revenue Share by Country (2017-2028)
Figure 39. United States Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Congenital Heart Disease Occluder Device Sales Market Share by Type (2017-2028)
Figure 42. Europe Congenital Heart Disease Occluder Device Revenue Market Share by Type (2017-2028)
Figure 43. Europe Congenital Heart Disease Occluder Device Sales Market Share by Application (2017-2028)
Figure 44. Europe Congenital Heart Disease Occluder Device Revenue Market Share by Application (2017-2028)
Figure 45. Europe Congenital Heart Disease Occluder Device Sales Share by Country (2017-2028)
Figure 46. Europe Congenital Heart Disease Occluder Device Revenue Share by Country (2017-2028)
Figure 47. Germany Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 48. France Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Congenital Heart Disease Occluder Device Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Congenital Heart Disease Occluder Device Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Congenital Heart Disease Occluder Device Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Congenital Heart Disease Occluder Device Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Congenital Heart Disease Occluder Device Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Congenital Heart Disease Occluder Device Revenue Share by Region (2017-2028)
Figure 58. China Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 61. India Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Congenital Heart Disease Occluder Device Sales Market Share by Type (2017-2028)
Figure 68. Latin America Congenital Heart Disease Occluder Device Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Congenital Heart Disease Occluder Device Sales Market Share by Application (2017-2028)
Figure 70. Latin America Congenital Heart Disease Occluder Device Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Congenital Heart Disease Occluder Device Sales Share by Country (2017-2028)
Figure 72. Latin America Congenital Heart Disease Occluder Device Revenue Share by Country (2017-2028)
Figure 73. Mexico Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Congenital Heart Disease Occluder Device Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Congenital Heart Disease Occluder Device Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Congenital Heart Disease Occluder Device Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Congenital Heart Disease Occluder Device Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Congenital Heart Disease Occluder Device Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Congenital Heart Disease Occluder Device Revenue Share by Country (2017-2028)
Figure 82. Turkey Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Congenital Heart Disease Occluder Device Revenue (2017-2028) & (US$ Million)
Figure 85. Congenital Heart Disease Occluder Device Value Chain
Figure 86. Congenital Heart Disease Occluder Device Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed